We agree strongly with Kremer et al that "metrics are essential for evaluating disease activity in patients with rheumatoid arthritis (RA)."¹ Nonetheless, data reported from the Corrona and the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) registries for Clinical Disease Activity Index (CDAI) and Routine Assessment of Patient Index Data 3 (RAPID3) are quite similar to those reported in the initial 2008 RAPID3 report.².

中文翻译：

---

类风湿性关节炎的定量措施和管理是否应该不仅仅包括控制炎症活动？

我们非常同意 Kremer 等人的观点，即“指标对于评估类风湿关节炎 (RA) 患者的疾病活动至关重要。” ¹尽管如此，Corrona 和 Brigham 和妇女类风湿性关节炎序列研究 (BRASS) 登记处的临床疾病活动指数 (CDAI) 和患者指数数据的常规评估 3 (RAPID3) 报告的数据与 2008 年最初报告的数据非常相似RAPID3 报告。² .